Skip to main content
Year archive

Prism Medico and Pharmacy Ltd. — 2023 filings

All 76 regulatory filings released by Prism Medico and Pharmacy Ltd. (512217) in 2023, sourced directly from the official regulator.

76 Filings
2023 Period
2023 filings (76)
Filing Released Lang
Dear Sir/Madam, With reference to the captioned subject, please find the attached revised outcome of Board Meeting. You are requested to kindly take the same on record and oblige. ....
Regulatory Filings
2023-11-09 English
Dear Sir/Madam, Pursuant to Regulation 23(9) of SEBI (LODR) Regulations, 2015 please find enclosed herewith details of related party transactions for the half year ended 30th September, ....
Regulatory Filings
2023-11-08 English
Dear Sir/Madam, Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform ....
Regulatory Filings
2023-11-08 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve Dear Sir/Madam, With ....
Regulatory Filings
2023-11-01 English
Dear Sir/Madam, Please find attached herewith copy of compliance certificate issued by the RTA for the quarter ended 30th September, 2023 pursuant to Regulation 74(5) of SEBI (Depositories ....
Regulatory Filings
2023-10-07 English
Dear Sir/Madam, Please find the attached intimation under Regulation 57(4) of SEBI (LODR) Regulations, 2015. Thanking You.
Regulatory Filings
2023-10-07 English
Dear Sir/Madam, Please find the attached statement of investment complaints as per Regulation 13(3) of SEBI (LODR) Regulations, 2015. Thanking You.
Regulatory Filings
2023-10-07 English
Dear Sir/Madam, Please find attached herewith copy of compliance certificate issued by RTA for the quarter ended 30th September, 2023 pursuant to Regulation 74(5) of SEBI (LODR) Regulations, ....
Regulatory Filings
2023-10-07 English
Dear Sir/Madam, Please find the attached intimation under Regulation 57(5) of SEBI (LODR) Regulations, 2015. Thanking You.
Regulatory Filings
2023-10-07 English
Dear Sir/Madam, Please find attached herewith Scrutinizer''s Report on remote e-voting and e-voting at the 21st Annual General Meeting of the company held on 30th September, 2023 at ....
Regulatory Filings
2023-10-02 English
Dear Sir/Madam, Please find the attached intimation of closure of trading window. Thanking You.
Regulatory Filings
2023-09-30 English
Dear Sir/Madam, Please find attached herewith proceedings of Annual General Meeting. Thanking You.
Regulatory Filings
2023-09-30 English
Dear Sir/Madam, Please find attached herewith outcome of 21st Annual General Meeting held today i.e. 30th September, 2023 at 12:30 P.M. through Video Conferencing/Other Audio Visual ....
Regulatory Filings
2023-09-30 English
Dear Sir/Madam, Please find the attached details of cut off/record date for the purpose of 21st Annual General Meeting scheduled to be held on Saturday the 30th day of September, 2023 ....
Regulatory Filings
2023-09-12 English
Dear Sir/Madam, Please find the attached intimation of book closure for the purpose of 21st Annual General Meeting of the company scheduled to be held on Saturday the 30th day of September, ....
Regulatory Filings
2023-09-12 English
Dear Sir/Madam, Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith ....
Regulatory Filings
2023-09-05 English
Dear Sir/Madam, In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith ....
Regulatory Filings
2023-09-04 English
Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith ....
Regulatory Filings
2023-09-04 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2023 ,inter alia, to consider and approve ? To consider and ....
Regulatory Filings
2023-08-31 English
Dear Sir/Madam, Please find enclosed herewith Scrutinizer''s Report on remote e-voting and e-voting at the e-EOGM held on 14th August, 2023 at 12:30 P.M. through Video Conferencing/Other ....
Regulatory Filings
2023-08-16 English
Dear Sir/Madam, Please find the attached herewith the proceedings of Extra Ordinary General Meeting held on 14th August, 2023 at 12:30 P.M. through Video Conferencing/Other Audio Visual ....
Regulatory Filings
2023-08-14 English
Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors ....
Regulatory Filings
2023-08-14 English
Dear Sir/Madam, Please find attached herewith outcome of Extra Ordinary General Meeting held on 14th August, 2023 at 12:30 P.M. through Video Conferencing/Other Audio Visual Means. Thanking ...
Regulatory Filings
2023-08-14 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve Dear Sir/Madam, With ....
Regulatory Filings
2023-08-07 English
Dear Sir/Madam, The outcome of the Board Meeting held on 20th July, 2023 was submitted with the stock exchange on the same day i.e. on 20th July, 2023 itself. However, since inadvertently ....
Regulatory Filings
2023-07-24 English
Dear Sir/Madam, The Board of Directors of the company have fixed the date for closure of Register of Members and Share Transfer Books from 08th August, 2023 to 14th August, 2023 (both ....
Regulatory Filings
2023-07-20 English
Dear Sir/Madam, Please find attached herewith the notice of extra ordinary general meeting to be held on 14th August, 2023 at 12:30 P.M. through VC/OAVM. You are requested to take ....
Regulatory Filings
2023-07-20 English
Dear Sir/Madam, Pursuant to Section 91 of the Companies Act, 2023 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors ....
Regulatory Filings
2023-07-20 English
Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the outcome of meeting of the ....
Regulatory Filings
2023-07-20 English
With reference to the captioned subject please find the attached herewith a report on investor complaints for the quarter ended 30th June, 2023. You are requested to kindly take the ....
Regulatory Filings
2023-07-14 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 we hereby furnish a copy of compliance certificate issued by the ....
Regulatory Filings
2023-07-14 English
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramit Walia & Charanjit Singh Bhatia
Regulatory Filings
2023-07-07 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramit Valia
Regulatory Filings
2023-07-07 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Charanjit Singh Bhatia
Regulatory Filings
2023-07-05 English
Pursuant to Regulation 57(5) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), we hereby confirm that the company has ....
Regulatory Filings
2023-07-03 English
Pursuant to code of conduct to regulate, monitor and report trading by the insiders (Code) and applicable SEBI Regulations, we would like to inform you that trading window for dealing ....
Regulatory Filings
2023-06-30 English
Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), it is informed that the company has ....
Regulatory Filings
2023-06-26 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Galaxy Vitacare Pvt Ltd, Paramjeet Kaurand ....
Regulatory Filings
2023-06-19 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ramit Walia
Regulatory Filings
2023-06-19 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parmjeet Kaurand Jasjot Singh
Regulatory Filings
2023-06-16 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Galaxy Vitacare Pvt Ltd
Regulatory Filings
2023-06-16 English
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith the details of Related Party Transactions (RPT's) ....
Regulatory Filings
2023-05-30 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....
Regulatory Filings
2023-05-30 English
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajooni Biotech Ltd & Jasjot Singh, ....
Regulatory Filings
2023-05-29 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Galaxy Vitacare Pvt Ltd
Regulatory Filings
2023-05-25 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Symbiosis Pharmaceuticals Pvt Ltd
Major Shareholding Notification
2023-05-25 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajooni Biotech Ltd & Jasjot Singh
Regulatory Filings
2023-05-25 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve With reference to ....
Board/Management Information
2023-05-22 English
With reference to Regulation 6(1) and Regulation 30 read with Clause 7 of Para A of Schedule III of the SEBI (LODR) Regulations, 2015 we do hereby inform that the Board of Directors of ....
Regulatory Filings
2023-05-17 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....
Regulatory Filings
2023-05-16 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....
Regulatory Filings
2023-05-16 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....
Regulatory Filings
2023-05-16 English
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....
Regulatory Filings
2023-05-16 English
With reference to the SEBI circular number SEBI/HO/DDHS/CIR/P/2018/144 dated 26th December, 2018 (as updated from time to time) with reference to fund raising by issuance of debt securities ....
Regulatory Filings
2023-04-29 English
This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India (Listing Obligations ....
Regulatory Filings
2023-04-28 English
We herewith enclose a certificate issued by the Practicing Company Secretary for the financial year ended 31st March, 2023 pursuant to Regulation 40(9) of the Securities and Exchange Board ....
Regulatory Filings
2023-04-28 English
Pursuant to Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith certificate certifying ....
Regulatory Filings
2023-04-28 English
With reference to the above captioned subject report on investor complaints for the quarter ended 31st March, 2023 is attached herewith. You are requested to kindly take the same on ....
Regulatory Filings
2023-04-20 English
Dear Sir / Madam, With reference to the above captioned subject it is hereby informed that the provisions of Regulation 27 on Corporate Governance of Securities and Exchange Board of ....
Regulatory Filings
2023-04-20 English
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 we hereby furnish a copy of compliance certificate issued by the ....
Regulatory Filings
2023-04-15 English
Pursuant to Regulation 57(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), we hereby confirm that the company ....
Regulatory Filings
2023-04-07 English
Pursuant to Code of Conduct to regulate, monitor and report Trading by Insiders ('Code') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in ....
Regulatory Filings
2023-03-31 English
Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement to the Equity Shareholders of Prism Medico and Pharmacy Ltd ("Target Company").
Regulatory Filings
2023-03-14 English
Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Offer Opening Public Announcement to the shareholders of Prism Medico and Pharmacy Ltd ("Target Company").
M&A Activity
2023-02-20 English
Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Submission of Advertisement of committee of independent directors in terms of Regulation 26 (7) of ....
Regulatory Filings
2023-02-17 English
The Committee of Independent Directors at its meeting held on today discussed, analysed and reviewed that the open offer given by Acquirers pursuant to Public Announcement dated 28th November, ....
M&A Activity
2023-02-16 English
Dear Sir/Madam, With respect to the captioned subject it is hereby informed that a meeting of Board of Directors of the company was held on 13th February, 2023 for the approval of Unaudited ....
Regulatory Filings
2023-02-14 English
Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors ....
Regulatory Filings
2023-02-13 English
Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Corrigendum to the detailed Public Statement to the Shareholders of Prism Medico and Pharmacy Ltd ....
Regulatory Filings
2023-02-09 English
Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Equity Shareholders of Prism Medico and Pharmacy Ltd ("Target ....
M&A Activity
2023-02-09 English
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve Dear Sir / Madam, With ....
Regulatory Filings
2023-02-03 English
Dear Sir / Madam, This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of ....
Regulatory Filings
2023-01-28 English
Dear Sir / Madam, With reference to the above captioned subject it is hereby informed that the provisions of Regulation 27 on Corporate Governance of Securities and Exchange Board of ....
Regulatory Filings
2023-01-23 English
Dear Sir / Madam, With reference to the above captioned subject report on investor complaints for the quarter ended 31st December, 2022 is attached herewith. You are requested to ....
Regulatory Filings
2023-01-16 English
Dear Sir/Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 we hereby furnish a copy of compliance certificate ....
Regulatory Filings
2023-01-14 English
Pursuant to Code of Conduct to regulate, monitor and report Trading by Insiders ('Code') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in ....
Regulatory Filings
2023-01-02 English